This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from Prilenia Therapeutics”.
In the first article, Brad Loren, Matthew Marrone, and Christopher Singer, of intellectual property and technology law firm McAndrews, Held & Malloy, speak about quantum computing and its benefits to drug discovery. In the second article, CEO of Prilenia Therapeutics, Dr Michael Hayden tells Lu Rahman why he has dedicated his career to advancing research into Huntington’s Disease and other neurodegenerative diseases.